Axiom Advisory’s Amgen AMGN Stock Holding History

Axiom Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.39M	Buy	7,296 +227	+3%	+$74.3K	0.02%	103
2024 Q2	$2.08M	Buy	+7,069	New	+$2.08M	0.02%	103

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Axiom Advisory's AMGN Position: Q3 2024 in Review

Axiom Advisory increased its Amgen (AMGN) stake by 3.2% in Q3 2024, buying an estimated $74.3K and bringing the position to 7,296 shares worth $2.39M. The position accounts for 0.02% of the portfolio, ranked #103.

Axiom Advisory first reported a position in AMGN in Q2 2024 and has held it in 2 quarters since. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

Axiom Advisory held 7,296 shares of Amgen worth $2.39M as of Q3 2024.
Axiom Advisory bought 227 Amgen shares in Q3 2024, an estimated $74.3K.
Amgen made up 0.02% of Axiom Advisory's portfolio in Q3 2024, its #103 holding.
Axiom Advisory first reported a position in Amgen in Q2 2024 and has held it in 2 quarters since.
2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Axiom Advisory's 13F filing for Q3 2024, filed 7 Oct 2024.